AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 152 filers reported holding AMYLYX PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,474,786 | -15.0% | 681,310 | +0.2% | 0.75% | -5.3% |
| Q2 2023 | $14,668,355 | -36.7% | 680,035 | -13.9% | 0.80% | -41.9% |
| Q1 2023 | $23,166,600 | -4.3% | 789,591 | +20.5% | 1.37% | -8.7% |
| Q4 2022 | $24,202,804 | +82.2% | 655,015 | +38.8% | 1.50% | +78.5% |
| Q3 2022 | $13,284,000 | – | 471,887 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,088,333 | $224,963,904 | 6.32% |
| Alpha Wave Global, LP | 821,220 | $30,344,079 | 5.54% |
| Ghost Tree Capital, LLC | 350,000 | $12,933,000 | 5.52% |
| Boxer Capital, LLC | 2,084,000 | $77,003,800 | 4.06% |
| Altium Capital Management LP | 140,000 | $5,173,000 | 2.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,693,000 | $99,506,350 | 2.06% |
| Iron Triangle Partners LP | 240,240 | $8,876,868 | 1.59% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 655,015 | $24,202,804 | 1.50% |
| EMERALD ADVISERS, LLC | 836,909 | $30,923,788 | 1.49% |
| GREAT POINT PARTNERS LLC | 190,000 | $7,020,500 | 1.38% |